Five Prime Therapeutics, Inc. Net Profit Margin 2013-2020 | FPRX
Five Prime Therapeutics, Inc. net profit margin from 2013 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2020-12-31 | $0.01B | $-0.08B | -700.00% |
| 2020-09-30 | $0.02B | $-0.09B | -587.50% |
| 2020-06-30 | $0.02B | $-0.10B | -611.76% |
| 2020-03-31 | $0.02B | $-0.12B | -711.76% |
| 2019-12-31 | $0.01B | $-0.14B | -971.43% |
| 2019-09-30 | $0.02B | $-0.14B | -960.00% |
| 2019-06-30 | $0.02B | $-0.16B | -861.11% |
| 2019-03-31 | $0.02B | $-0.16B | -673.91% |
| 2018-12-31 | $0.05B | $-0.14B | -280.00% |
| 2018-09-30 | $0.06B | $-0.13B | -220.34% |
| 2018-06-30 | $0.06B | $-0.13B | -206.56% |
| 2018-03-31 | $0.06B | $-0.14B | -222.95% |
| 2017-12-31 | $0.04B | $-0.15B | -382.05% |
| 2017-09-30 | $0.03B | $-0.14B | -411.76% |
| 2017-06-30 | $0.03B | $-0.12B | -351.52% |
| 2017-03-31 | $0.03B | $-0.09B | -250.00% |
| 2016-12-31 | $0.03B | $-0.07B | -209.68% |
| 2016-09-30 | $0.39B | $0.25B | 65.03% |
| 2016-06-30 | $0.39B | $0.25B | 63.90% |
| 2016-03-31 | $0.38B | $0.25B | 64.92% |
| 2015-12-31 | $0.38B | $0.25B | 65.96% |
| 2015-09-30 | $0.02B | $-0.06B | -276.19% |
| 2015-06-30 | $0.02B | $-0.04B | -195.24% |
| 2015-03-31 | $0.02B | $-0.04B | -200.00% |
| 2014-12-31 | $0.02B | $-0.04B | -190.00% |
| 2014-09-30 | $0.02B | $-0.03B | -173.68% |
| 2014-06-30 | $0.02B | $-0.03B | -206.25% |
| 2014-03-31 | $0.02B | $-0.03B | -200.00% |
| 2013-12-31 | $0.01B | $-0.03B | -200.00% |
| 2013-09-30 | $0.01B | $-0.03B | -207.69% |
